Biomedical technology firm sells 67,706 shares at $2.10, a 25% discount
By Toni Weeks
San Luis Obispo, Calif., Feb. 9 – HCi Viocare completed a $142,183 private placement of stock on Feb. 2, according to an 8-K filing with the Securities and Exchange Commission.
The company sold 67,706 common shares at $2.10 per share. The price per share reflects a 25% discount to the Jan. 30 closing share price of $2.80.
The company is developing a portfolio of biomedical technologies to address unmet needs in the diabetic foot, Prosthetics & Orthotics and other health and well-being areas for licensing to established industry participants. It is also creating an independent chain of P&O and diabetic foot clinics in Europe and the Middle East. The company has its executive offices in Athens and its research and development center in Glasgow.
| Issuer: | HCi Viocare
|
| Issue: | Common stock
|
| Amount: | $142,183
|
| Shares: | 67,706
|
| Price: | $2.10
|
| Warrants: | No
|
| Settlement date: | Feb. 2
|
| Stock symbol: | OTCBB: VICA
|
| Stock price: | $2.80 at close Jan. 30
|
| Market capitalization: | $16.51 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
